https://mobile.nytimes.com/2017/04/06/health/fda-genetic-tests-23andme.html
For the first time, the Food and Drug Administration said it would allow a company to sell genetic tests for disease risk directly to consumers, providing people with information about the likelihood that they could develop various conditions, including Parkinson's and Alzheimer's.
The move on Thursday is a turnaround for the agency, which had imposed a moratorium in 2013 on disease tests sold by the company, 23andMe, which is based in Mountain View, Calif. The decision is expected to open the floodgates for more direct-to-consumer tests for disease risks, drawing a road map for other companies to do the same thing.
If you could take such a test, would you? Or would you rather just take things as they come?
(Score: 0) by Anonymous Coward on Sunday April 09 2017, @02:41AM
Pay for the test then pay more for insurance after they sell your information, sounds like a deal to me!
Why didn't trump just press the button and save us all a lot of grief?